Last reviewed · How we verify
NCT07282496
Evaluation of VEDAN RT-90 Resistant Cassava Starch for Glycemic Control and Prebiotic Fiber Development in a Human Trial
NA trial testing RT-90 resistant tapioca starch in Resistant Starch in 115 participants. Not yet recruiting.
31 August 2026
Quick facts
| Lead sponsor | Chung Shan Medical University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 115 |
| Start date | 20 December 2025 |
| Primary completion | 31 August 2026 |
| Estimated completion | 31 October 2026 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- RT-90 resistant tapioca starch
- control group — full drug profile →
- Commercially available resistant starch
Conditions studied
- Resistant Starch — all drugs for Resistant Starch →
- Tapioca Starch — all drugs for Tapioca Starch →
- Prebiotic Fiber — all drugs for Prebiotic Fiber →
- Blood Sugar — all drugs for Blood Sugar →
Sponsor
Chung Shan Medical University
Who can join
Adults 18 to 65, any sex, with Resistant Starch or Tapioca Starch. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to investigate the effects of RT-90 resistant cassava starch on glycemic control using a human dietary trial and to evaluate its potential as a prebiotic fiber supplement. This study will assess the efficacy of RT-90 resistant cassava starch in improving glycemic control, body composition, and gut microbiome in healthy individuals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07282496
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Chung Shan Medical University trials
Trials by the same sponsor.
- NCT07443540 — The Effect of Acupuncture on Pulmonary Function Recovery Following Lung Resection · NA · not yet recruiting
- NCT07504029 — Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides · NA · recruiting
- NCT07252557 — Mouthwash Temperature and Oral Mucositis in Head and Neck Radiotherapy · NA · not yet recruiting
- NCT07504016 — Development of a Novel Cookie Formulation and Evaluation of Its Effects on Glycemic Control in Healthy Individuals · NA · completed
- NCT07018102 — Nurse-Led Bedside Trunk Control Care Program · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07282496 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chung Shan Medical University
- Last refreshed: 15 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07282496.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing